Filter
7950
Filtered Results: 7950
Text search:
drugs
act
Featured
Recommendations
666
New Publications
2015
Language
Document type
No document type
4724
Studies & Reports
1194
Guidelines
1006
Manuals
361
Strategic & Response Plan
237
Fact sheets
174
Training Material
132
Situation Updates
37
Infographics
31
Brochures
25
Resource Platforms
18
Online Courses
7
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
India
466
Global
257
Kenya
230
South Africa
185
Ethiopia
161
Uganda
160
Nigeria
156
Western and Central Europe
154
Nepal
142
Sierra Leone
142
Tanzania
120
Liberia
120
Zambia
117
Malawi
113
Latin America and the Carribbean
112
Ghana
103
Bangladesh
98
Rwanda
97
Africa
97
Myanmar / Burma
95
Ukraine
87
Eastern Europe
75
Namibia
66
Philippines
65
Zimbabwe
58
Congo, Democratic Republic of
57
Russia
54
South–East Asia Region
51
Indonesia
51
Asia
50
Senegal
49
Syria
47
Cambodia
45
Lesotho
43
Burkina Faso
42
Mozambique
40
Germany
37
South Sudan
37
Botswana
35
Colombia
33
Brazil
31
Eswatini/ Swaziland
29
Haiti
26
Venezuela
26
Cameroon
23
West and Central Africa
23
Middle East and North Africa
22
East and Southern Africa
22
Guinea
21
Tajikistan
20
Benin
19
Peru
19
Eastern Europe and Central Asia
19
Paraguay
19
Argentina
19
Yemen
18
Chile
16
Sudan
16
Afghanistan
15
USA
15
Pakistan
15
Albania
14
Vietnam
13
Bolivia
12
Moldova
12
Georgia
12
Central African Republic
12
Thailand
11
Lebanon
11
Somalia
11
Madagascar
11
China
10
Laos
10
Mali
10
Armenia
9
Western Pacific Region
9
North Macedonia
8
Mexico
8
Ecuador
8
El Salvador
7
North America
7
Sri Lanka
7
Niger
6
Jordan
6
United Kingdom
6
Palestine
6
Iraq
6
Turkey
5
Angola
5
Libya
5
Bhutan
5
Iran
4
Fiji
4
Kyrgyzstan
4
Uzbekistan
4
Burundi
4
Guinea-Bissau
4
Saudi Arabia
4
Jamaica
4
Spain
4
Southern Africa
4
Côte d’Ivoire / Ivory Coast
4
Papua New Guinea
4
Egypt
4
Romania
4
Poland
4
Chad
4
Timor Leste/ East Timor
3
Serbia
3
Gambia
3
Kazakhstan
3
Morocco
3
Uruguay
3
Belarus
3
Djibouti
3
Greece
3
Canada
2
Singapore
2
Estonia
2
Mongolia
2
Qatar
2
Hungary
2
Lithuania
2
Gabon
2
Turkmenistan
2
Belgium
2
France
2
Mauritius
2
Tunisia
2
Portugal
2
Honduras
2
North Korea
1
Switzerland
1
Australia
1
Congo-Brazzaville
1
Bulgaria
1
Mauritania
1
Italy
1
Dominican Republic
1
Ireland
1
Japan
1
Denmark
1
Maldives
1
Norway
1
Azerbaijan
1
Latvia
1
Nicaragua
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
3065
Clinical Guidelines
668
Public Health
377
Women & Child Health
331
Key Resources
268
Capacity Building
132
Pharmacy & Technologies
83
Annual Report MEDBOX
2
Toolboxes
HIV
851
Mental Health
781
TB
670
COVID-19
446
AMR
342
NTDs
301
Pharmacy
241
Caregiver
183
NCDs
168
Rapid Response
148
Ebola & Marburg
143
Conflict
122
Refugee
121
Planetary Health
119
Disability
116
Global Health Education
82
Health Financing Toolbox
74
Natural Hazards
57
Zika
36
Cholera
31
Specific Hazards
29
Polio
28
Social Ethics
25
Malaria
9
South Sudan
2
100 test methods for 100 active pharmaceutical ingredients
For existing Minilab projects that want to replace old manuals or initiatives that want to start new projects, the new "Minilab Edition 2020" can be obtained at the preferential price of 50 € from our logistic partner Technologie Transfer...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Background
The core clinical symptoms of addiction include an enhanced incentive for drug taking (craving), impaired self-control (impulsivity and compulsivity), emotional dysregulation (negative mood) and increased stress reactivity. Symptoms related to impaired self-control involve reduced activi...
This e-course will guide you through the essentials of latest existing WHO guidelines and policy recommendations on drug-resistant TB. You will also learn more about the rationale behind the WHO recommendations for the management of DR-TB, implementation considerations for different regimens for eli...
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
With the goal of ending viral hepatitis as a public health threat by 2030, the Regional Action Plan will provide an actionable framework for implementing evidence-based interventions at scale. It will be informed through strategic monitoring of the response, that must be equitable and sustainable an...
The Ethiopian Food and Drug Administration (EFDA) is mandated, in the proclamation 661/2009, to ensure the safety, quality and efficacy of medicines. To achieve this, the authority has been working on different regulatory activities. The medicine market authorization system is one of the top priorit...
A resource for the continued implementation of the Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively
Drug-Resistant Tuberculosis in the WHO European Region 2011-2015
Please download the whole Document (large size 28 MB) directly from the website
Zambia has recognised the Public Health threat of antimicrobial resistance and its impact on morbidity and mortality, as well as the subsequent economic consequences. The country has recorded microorganisms which have developed resistance to antimicrobial drugs. Notable among these are; Multidrug Re...
FDA’s compounding program aims to protect patients from unsafe, ineffective and poor quality compounded drugs, while preserving access to lawfully-marketed compounded drugs for patients who have a medical need for them. Here you can find informations to laws &policies, compliance action, ....
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th...
This paper focuses on the Sustainable Development Goals related to poverty, economic growth, inequality, health, food production and the environment. It presents concrete examples of the underlying and complex aspects of antibiotic resistance and its impacts across different Sustainable Development ...
Schools are generally the most popular setting for drug-use-
prevention programmes, and are used both by governmental and
non-governmental agencies. This may be for many reasons: ease of
obtaining funding for school drug-use-prevention programmes, the
captive audience, and the popular perception...
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordinating Group on Antimicrobial Resistance who release...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
